Specify a stock or a cryptocurrency in the search bar to get a summary
Helius Medical Technologies Inc Class A
HSDTHelius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania. Address: 642 Newtown Yardley Road, Newtown, PA, United States, 18940
Analytics
WallStreet Target Price
4 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures HSDT
Dividend Analytics HSDT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History HSDT
Stock Valuation HSDT
Financials HSDT
Results | 2019 | Dynamics |